Pittenger & Anderson Inc. raised its stake in UnitedHealth Group Inc. (NYSE:UNH) by 1.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,315 shares of the healthcare conglomerate’s stock after buying an additional 365 shares during the period. Pittenger & Anderson Inc.’s holdings in UnitedHealth Group were worth $3,433,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of UNH. Vontobel Asset Management Inc. increased its stake in UnitedHealth Group by 23.0% in the first quarter. Vontobel Asset Management Inc. now owns 2,032,763 shares of the healthcare conglomerate’s stock valued at $271,445,000 after buying an additional 380,077 shares in the last quarter. Fisher Asset Management LLC acquired a new stake in UnitedHealth Group during the first quarter valued at approximately $361,000. First Financial Corp IN increased its stake in UnitedHealth Group by 3.8% in the first quarter. First Financial Corp IN now owns 10,004 shares of the healthcare conglomerate’s stock valued at $1,289,000 after buying an additional 366 shares in the last quarter. Davis R M Inc. increased its stake in UnitedHealth Group by 12.2% in the first quarter. Davis R M Inc. now owns 2,595 shares of the healthcare conglomerate’s stock valued at $334,000 after buying an additional 283 shares in the last quarter. Finally, Private Trust Co. NA increased its stake in UnitedHealth Group by 4.5% in the first quarter. Private Trust Co. NA now owns 6,864 shares of the healthcare conglomerate’s stock valued at $884,000 after buying an additional 298 shares in the last quarter. 85.78% of the stock is owned by institutional investors.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.82% on Monday, reaching $139.36. 753,583 shares of the company traded hands. The firm has a 50 day moving average of $138.79 and a 200-day moving average of $135.32. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The stock has a market capitalization of $132.73 billion, a PE ratio of 21.81 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. The business earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, analysts anticipate that UnitedHealth Group Inc. will post $7.92 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
UNH has been the subject of several recent analyst reports. Leerink Swann reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Sanford C. Bernstein started coverage on shares of UnitedHealth Group in a report on Wednesday, June 15th. They set an “outperform” rating and a $171.00 price objective for the company. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Finally, Wolfe Research started coverage on shares of UnitedHealth Group in a research note on Tuesday, June 28th. They set an “outperform” rating and a $172.00 target price for the company. One research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $154.96.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.65% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.